Serum Levels of 25-Hydroxyvitamin D in Chronic Plaque Psoriasis

Serum Levels of 25-Hydroxyvitamin D in Chronic Plaque Psoriasis

Show other versions (1)

Background: Psoriasis is an immune mediated inflammatory disease that involves the innate and acquired arm of immunologic system. The regulatory role for vitamin D in immune system is suggested by presence of vitamin D receptors on activated lymphocytes and suppressive or inhibiting effect of 1,25-...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ayush Jha, Manisha Singh Basukala, Rima Shrestha, Roji Dawadi
Format:	Article
Language:	English
Published:	Society of Dermatologists, Venereologists and Leprologists of Nepal (SODVELON) 2023-03-01
Series:	Nepal Journal of Dermatology, Venereology & Leprology
Subjects:	psoriasis psoriasis area severity index 25-hydroxyvitamin D
Online Access:	https://nepjol.info/index.php/NJDVL/article/view/52130
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Serum Levels of 25-Hydroxyvitamin D in Chronic Plaque Psoriasis
by: Ayush Jha, et al.
Published: (2023-03-01)

Efficacy and safety of mirikizumab (LY3074828) in chronic plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials
by: Taimoor Ashraf, et al.
Published: (2025-07-01)

Case–Control Study of Inflammatory Mediators in Psoriasis and its Correlation with the Psoriasis Area and Severity Index
by: Jeevith Chandrashekara Reddy, et al.
Published: (2025-04-01)

25-hydroxyvitamin D Serum Level and Risk of Knee Osteoarthritis in the Elderly
by: Indira Ayu Putri, et al.
Published: (2025-03-01)

Correlation between 25-hydroxyvitamin D and severe headache or migraine: evidence from NHANES database
by: Xiaolei Zhang, et al.
Published: (2024-12-01)

The role of psychological stress in the pathogenesis of psoriasis
by: Dongyun Lei, et al.
Published: (2025-08-01)

Serious generalized pustular psoriasis with evolution to plaque psoriasis: approach with spesolimab
by: Liz S. Gea, et al.
Published: (2024-10-01)

A large-scale retrospective study in China explores risk factors for disease severity in plaque psoriasis
by: Huiwei Wang, et al.
Published: (2024-10-01)

Novel Approach for Evaluating the Effectiveness of Biological Drugs in Patients with Plaque Psoriasis: Real-World Experience of a Single-Centre Study in Poland
by: Kimak-Pielas A, et al.
Published: (2025-06-01)

Stir Up the Sun Therapy: Topical PUVASOL Therapy in Palmoplantar Psoriasis
by: Swamy Kumar Rashmi, et al.
Published: (2025-07-01)

Tobacco Smoking Was Positively Associated with Disease Relapse at week 24 and 48 Among Patients with Psoriasis Vulgaris in Shanghai: A Prospective Study
by: Shen F, et al.
Published: (2025-07-01)

Correlation between Psoriasis Area Severity Index and Dermatology Life Quality Index in Patients of Psoriasis: A Cross-Sectional Study
by: S Drishya, et al.
Published: (2025-03-01)

Correlation between Psoriasis Area Severity Index and Dermatology Life Quality Index in Patients of Psoriasis: A Cross-Sectional Study
by: S Drishya, et al.
Published: (2025-03-01)

Chronic Plaque Psoriasis
by: K.M. Luba, et al.
Published: (2006-10-01)

Are 25-hydroxyvitamin D deficiency and Helicobacter pylori infection more common in obese people?
by: Kenan Çadırcı, et al.
Published: (2024-04-01)

High Systemic Disease Risk and Therapeutic Delays in Plaque Psoriasis: A Retrospective Analysis of Apremilast Use in the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)
by: Kave Shams, et al.
Published: (2025-03-01)

Measurement Serum Levels of IFNY, IL-17 and IL-4 of Psoriasis patients in Al- Najaf City
by: Muhsin A. Al-Dhalimi, et al.
Published: (2013-12-01)

Association between serum uric acid and 25-hydroxyvitamin D<sub>3</sub> in maintenance hemodialysis patients
by: Qiu Fang-xin, et al.
Published: (2021-01-01)

S-MAPA: bridging the gap in psoriasis severity assessment
by: Trang Thi Thuy Vu, et al.
Published: (2025-05-01)

Ustekinumab Efficacy and Safety in Children with Plaque, Erythrodermic and Palmoplanar Forms of Psoriasis: Retrospective Cohort Study
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

The interplay between epidermal barrier distribution, microbiota composition, and immune infiltrate defines and stratifies psoriasis patients and is associated with disease severity
by: Elizabeth M. Ortega Rocha, et al.
Published: (2024-12-01)

Hard-to-Treat Areas in Psoriasis: An Underevaluated Part of the Disease
by: Adina-Mihaela Lupulescu, et al.
Published: (2025-03-01)

Assessment of Serum 25-hydroxyvitamin D Levels at the First Manifestation of Multiple Sclerosis in Children and Adolescents
by: Müge Ayanoğlu, et al.
Published: (2022-09-01)

The Relationship Between Novel Inflammatory Markers and Serum 25‐Hydroxyvitamin D Among US Adults
by: Hang Zhao, et al.
Published: (2025-01-01)

Sex-specific relationship between serum 25-hydroxyvitamin D concentrations and antinuclear antibodies in U.S. adults, NHANES 2001–2004
by: Zhen Gui, et al.
Published: (2024-12-01)

Association of serum 25-hydroxyvitamin D with the risk of depression in individuals with prediabetes and diabetes: A prospective cohort study
by: Huaxue Li, et al.
Published: (2025-06-01)

Treatment of severe plaque psoriasis complicated with HIV infection using secukinumab: a case report
by: JING Xiaolei, et al.
Published: (2025-04-01)

ASSOCIATION BETWEEN 25-HYDROXYVITAMIN D LEVELS AND GROWTH PARAMETERS IN THALASSEMIA WITH REPEATED BLOOD TRANSFUSION
by: Najma Khairani Harahap, et al.
Published: (2020-11-01)

The association between parameters of oral mucosal immunity and 25-hydroxyvitamin D in patients with rampant caries
by: A. S. Putneva, et al.
Published: (2022-01-01)

Serum 25-Hydroxyvitamin D Levels and Disease Activity in Patients with Systemic Lupus Erythematosus: An Exploratory Study in Western Mexico
by: Daniela Deossa-Piedrahita, et al.
Published: (2024-12-01)

Laboratory considerations in the assessment of 25-hydroxyvitamin D in pregnant women by automated immunoassays
by: Darya Ayad Khalid, et al.
Published: (2024-11-01)

Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01)

Association of serum 25-hydroxyvitamin D with sleep disorders in individuals with prediabetes and diabetes: a prospective cohort study
by: Guodong Liu, et al.
Published: (2025-04-01)

Combined 25-hydroxyvitamin D concentrations and physical activity on mortality in US stroke survivors: findings from the NHANES
by: Junqi Liao, et al.
Published: (2025-01-01)

Evaluation of the efficacy and safety of cold laser (Diode 808 nm) therapy in the treatment of localized plaque psoriasis: clinical, dermoscopic and ultrastructural study
by: Reham L. Gohar, et al.
Published: (2024-05-01)

Age-, season- and gender-specific reference intervals of serum 25-hydroxyvitamin D3 for healthy children (0 ~ 18 years old) in Nanning area of China
by: Dong-yi Zhou, et al.
Published: (2024-01-01)

Metabolic syndrome associated with psoriasis vulgaris in adults: A hospital-based study
by: Konda Chandrasekhar, et al.
Published: (2024-10-01)

PSORIASIS OF THE SCALP: METHODS OF TREATMENT AND CARE
by: A. I. Ermilova, et al.
Published: (2013-05-01)

Serum 25 hydroxyvitamin D was positively associated with hemoglobin and other anemia parameters in children: a cross-sectional study
by: Hongli Dong, et al.
Published: (2025-06-01)

Association between serum 25-hydroxyvitamin D and prostate cancer in middle-aged and elderly Americans: a national population-based analysis of NHANES 2001–2018
by: Guohui Zhang, et al.
Published: (2025-06-01)